1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow LaunXP Biomedical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. LXP1788 is administered intravenously via Port-A - Solid Tumor Malignancies, Cancer, Solid Cancers | Phase 1 | Recruiting | LaunXP Biomedical Co., Ltd. | 24 | 2024-12-31 | 2025-03-19 |
Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Taiwan (1)